Moleculin Biotech, Inc. MBRX
$0.61
+7.16%
at last close
Financials (TTM)
- Revenue
- —
- Net Income
- $-40,501,000
- Net Margin
- —
- Return on Equity
- -266.75%
- Debt-to-Equity
- —
- P/E Ratio
- —
- Price / Book
- 0.29
- Price / Sales
- —
Over the trailing twelve months, Moleculin Biotech, Inc. generated revenue of — and net income of $-40,501,000.
Key Stats
- Last Close
- $0.61
- Market Cap
- $4.35 million
- 52-Week Range
- $0.16 – $24.00
- Average Volume
- 1.58 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.